Stage IIB Skin Melanoma Completed Phase Trials for Benzalkonium (DB11105)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0054560 (Stage IIB Skin Melanoma) | Completed | Not Available |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01460875 | Recombinant Interferon Alfa-2b in Treating Patients With Melanoma | Treatment |